Beiswenger and Associates, Inc.
Product Research Engineering

Biosymtec Technologies
Medical Product Research

Beiswenger and Associates, Inc.

Kim A. Beiswenger
President and CEO

Beiswenger and Associates, Inc., was first formed in 1993 as a Product Research Engineering company and has completed more than 50 projects for clients; a few are shown below. To see the latest product concepts developed by the company and available for licensing, click on Beiswenger in the navigation bar.

The Biosymtec Technologies segment of the business has developed a unique medical product, ready for final design, and available for licensing. To review, click on Biosymtec in the navigation bar.

To contact me, click on Contact above.

Self-maintaining, special purpose scanner with one button operation. The machine was used to take hand written health data (BP, weight and answers) from elderly Heart Failure patients in their homes and automatically forward the data to a remote computer using OCR. Patents issued in U.S., Europe, China and Canada.

Touch-screen alarm clock with three color LCD display. The LCD can see the finger. To change the time, just touch the numeral needed to change. Complete product cost just $6 in a display carton. Two issued patents resulted. A version of this technology is available through Beiswenger and Associates.

All-new electric-convection barbecue grill, with highly competitive features, for a large gas grill manufacturer.   Grill produced a better barbecue flavor than the client's gas grills and cooked an eight-pound chicken in 38 minutes, so juicy there was a suggestion the user should be warned about spilling the chicken when it was removed from the grill.   Patent in process.

Provided the design and solid modeling of a complete line of boat navigation lights and horn, working with an engineering physicist. The lights were the "best-ever-tested" by Coast Guard. The two-mile lights were visible at four miles. Lens segments were ultrasonically welded together.

Beiswenger and Associates
Less than inch of wood stands between you and a burglar. In fact, 73% of burglars gain entry to a home by kicking the door in. One or two strong kicks to a door will allow
burglars entry into your home.

1. Conventional locks are at just the right height to kick in doors.

2. The two large holes required for installation of typical hardware weaken the door.

3. This new deadbolt lock is keyless and quick to operate.

4. The keyless touch pad is installed at a convenient height to use, well above the kick-in pressure point.

5. The height allows for easy viewing of callers.

6. Installation with four small holes doesn’t weaken the door.   Retaining slide shown cutaway to expose dead bolt.

7. A force-sensor in the lock triggers a camera in the keypad.

8. Photo is automatically sent to smartphone anywhere.

The above product concept is an intellectual property of Product Research Associates, LLC and is available for license and engineering design through Beiswenger and Associates, Inc.   A patent application has been filed with counsel.

The FBI’s figures show that nearly two-thirds of the total number of burglaries were home invasion burglaries (around 685,766 total in the U.S.). Of these, the biggest share (56.7%) were committed by forcible entry.

Contact me for a Final Design cost estimate. Kim Beiswenger, President & CEO.

  Biosymtec Technologies

Important medical technology available for license or aquisition

Used daily upon waking, the Biosymtec Monitor will detect and predict developing • non-respiratory infections, • reductions in lung function (exacerbations), and • respiratory infections (differentiating between the three) all before symptoms and clinical signs, such as a fever, occur.

The Biosymtec Monitor detects infections such as: • urinary tract infections, • bronchitis, • influenza, • pneumonia, • COVID-19 and variants, days before symptoms, allowing for early medical intervention including the use of antivirals and antibiotics, when they are most effective.

“I am going to prescribe this Biosymtec Monitor for your use upon waking each day. The Biosymtec Monitor is an antesigna device; that is, it detects infections before you have symptoms or clinical signs of an infection.  Early detection will get you to me before any developing symptoms cause you to go to the hospital.”

The Biosymtec Monitor is kept by the bedside so that it can be used upon waking, before getting out of bed. The dual probes are placed under the tongue, straddling the frenulum. A special core temperature is taken. Upon rising the patient blows hard through the monitor.
An AI algorithm delivers immediate results which are shown on the display.

The results are also immediately forwarded to the Biosymtec System where they are stored, graphed and the resulting graph is promptly made available to the physician's computer or tablet and to the patient's smartphone. The special graph shows exactly what has been displayed on the Biosymtec Monitor; in this case all green in each column.



“It is our belief the virus leaked sometime in late August or early September 2019,” said Michael McCaul - lead Republican on the U.S. House of Representatives Foreign Affairs Committee

"This is an actual Biosymtec graph of a patient we later suspected of having one of the first cases of COVID-19 in the U.S.   He acquired the infection on a train ride between Lancaster and Philadephia, Pennsylvania.   Very similar to COVID, it began with a cough, then a fever developed, followed by a respiratory infection on October 30.   On the left is a Biosymtec Monitor displaying a respiratory infection."

Front Page

The Biosymtec Monitor will replace the thermometer and peak-flow meter used now by pulmonary patients. Unlike the thermometer and peak-flow meter, the Biosymtec Monitor will also forward results to the patients’ physicians.

Will the patient still need a thermometer to check for a fever? No, the Biosymtec Monitor will serve also as a unique fever thermometer, indicating low grade or high grade fevers.

Cleaning the spirometer assembly is easy. It can be removed from the bottom of the Biosymtec Monitor, washed in soapy water, rinsed and air dried before being returned. The replaceable power cell is thereby also made accessible.



The Biosymtec Monitor was designed as an oral platform to acquire and analyze vital data non-invasively. The technology is based on the discovery that sublingual and pulmonary data, acquired from an individual upon waking and correlated by a unique AI algorithm, we call Aila, can determine the onset of an illness, days before symptoms or clinical signs such as a fever. (See also our Virtual Prototype)

  • Detects non-respiratory infections before symptoms,
  • Detects lung function issues before exacerbations,
  • Detects respiratory infections before symptoms, keeping COPD and asthma patients out of the hospital.

    Those will be the first three initial capabilities of the Biosymtec Monitor. The following are planned:

  • Read and produce patient's electrocardiogram (EKG),
  • Measure Forced Expiratory Volume at 1 second (FEV1),
  • Measure Forced Vital apacity (FVC),
  • Measure Fractional Exhaled Nitric Oxide (FeNO),
  • Measure Exhaled Oxygen percentage (eO%),
  • Measure waking heart rate (HR),
  • Measure Blood Oxygen Saturation (SpO2),
  • Measure Respiration Rate (RR), and possibly,
  • Read Blood Sugar levels with transmissive technology (others are working on it),

    We have also been studying (through published papers) the possibility that the Biosymtec Monitor could:

  • Detect lung cancer through exhaled breath (latest science news), and even,
  • Cure some cancers using orally introduced EMF! It's being done in Germany.
  • ekg

    Competitive Product Comparison


    Biosymtec Monitor

    • Easy-to-read, multi-color graphic display on front,
      [Note: Readable by anyone speaking any language.]
    • Temperature is taken near the sublingual artery, correlating closely with the body's core temperature,
    • Airflow is measured physically and electronically with a turbine,
    • Product forwards data for a 50-day graph of basal temperature, peak-flow percent of best and other data,
    • Predicts likelihood of respiratory and non-respiratory infections up to two or more days before symptoms occur.


    • Future numeric display on back,
    • Temperature taken at the lip,
    • Peak-flow percentage of best is not obtained,
    • Airflow is measured with a microphone,
    • Provides data for a graph only of current data. Basal data is not considered,
    • No predictive capability available to user.


    These are the primary markets for the Biosymtec Monitor, because patients with COPD, including chronic bronchitis, asthma and emphysema, must be treated early to avoid respiratory infections developing into pneumonia. They must be treated by their physicians before their symptoms get so bad they find themselves in a hospital ER.

    There are over 40 million with COPD and asthma in the U.S., 300 million worldwide, and the numbers are growing. During the research studies done in China, a Health Bureau physician said emphatically, after we commented on the local air polution, "In 10 years, everybody sick, in 10 years, everybody sick."

    There are many other markets.

    Heart Failure (CHF) patients must learn early if they have any infection, because infections further weaken their hearts.

    Cystic Fibrosis (CF) primarily affects the lungs, these patients are prone to chest infections. Early detection and early treatment are key.

    Healthcare Workers


    Development Status: The product research engineering of the Biosymtec Monitor has been completed, and the project is ready for the Final Design Phase followed by tooling. The cost of the Final Design Phase is estimated to be $500K (actual quotations from quality sources were obtained).

    Patent Status: A Provisional Patent Application has been submitted by patent counsel to the USPTO. The document must be updated before applying for Patent.

    Ownership: The Biosymtec Technology, including all aspects of the Biosymtec Monitor, the AI Algorithm, and Copyrighted graph template, are solely owned by
    Beiswenger and Associates, Inc. dba Biosymtec Technologies.

    Transferable Materials:
          •   AutoCAD file (Concept Engineering Layout),
          •   Non-functional model (Parts 3D printed from Layout),
          •   The AI Algorithm,
          •   Virtual Biosymtec Monitor using the AI Algorithm,
          •   Copyrighted Graph Template,
          •   Provisional Patent Application.

    License available: Terms and Provisions negotiable. Contact Kim A. Beiswenger

    Available for Aquisition: Terms negotiable. Contact Kim A. Beiswenger

    Project Support Offer: John L. Beiswenger, a product research engineer with 50+ years experience, will accept employment (remote, if beyond daily driving distance) for a period of one year. .

    Exploded view rendered from CAD layout.



          Please check the box, if you would like to receive our Newsletter.


    And what are we working on next?   A replacement for home-use thermometers.   A new low-cost device, called the Sign V by Dr. James A. Wilson MD, expressing the importance of the new device.   The Sign V tells the consumer what they need to know when they know they need it.   Read the logic behind it.